Literature DB >> 33947329

Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC).

Wendy Li1,2, Yang Sun3, Lin Dai4, Hongju Chen1,2,5, Bin Yi5, Junkun Niu3, Lan Wang3, Fengrui Zhang3, Juan Luo3, Kunhua Wang6, Rui Guo3, Lianwei Li1,2, Quan Zou7, Zhanshan Sam Ma8,9,10, Yinglei Miao11.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is one of the primary types of inflammatory bowel disease (IBD), the occurrence of which has been increasing worldwide. Although IBD is an intensively studied human microbiome-associated disease, research on Chinese populations remains relatively limited, particularly on the mucosal microbiome. The present study aimed to analyze the changes in the mucosal microbiome associated with UC from the perspectives of medical ecology and complex network analysis.
RESULTS: In total, 56 mucosal microbiome samples were collected from 28 Chinese UC patients and their healthy family partners, followed by amplicon sequencing. Based on sequencing data, we analyzed species diversity, shared species, and inter-species interactions at the whole community, main phyla, and core/periphery species levels. We identified four opportunistic "pathogens" (i.e., Clostridium tertium, Odoribacter splanchnicus, Ruminococcus gnavus, and Flavonifractor plautii) with potential significance for the diagnosis and treatment of UC, which were inhibited in healthy individuals, but unrestricted in the UC patients. In addition, we also discovered in this study: (i) The positive-to-negative links (P/N) ratio, which measures the balance of species interactions or inhibition effects in microbiome networks, was significantly higher in UC patients, indicating loss of inhibition against potentially opportunistic "pathogens" associated with dysbiosis. (ii) Previous studies have reported conflicting evidence regarding species diversity and composition between UC patients and healthy controls. Here, significant differences were found at the major phylum and core/periphery scales, but not at the whole community level. Thus, we argue that the paradoxical results found in existing studies are due to the scale effect.
CONCLUSIONS: Our results reveal changes in the ecology and network structure of the gut mucosal microbiome that might be associated with UC, and these changes might provide potential therapeutic mechanisms of UC. The four opportunistic pathogens that were identified in the present study deserve further investigation in future studies.

Entities:  

Keywords:  Core/periphery network; Inflammatory bowel disease; Mucosal microbiome; Species co-occurrence network; Species diversity; Ulcerative colitis

Year:  2021        PMID: 33947329     DOI: 10.1186/s12866-021-02201-6

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


  54 in total

1.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific.

Authors:  Julia Benckert; Nina Schmolka; Cornelia Kreschel; Markus Josef Zoller; Andreas Sturm; Bertram Wiedenmann; Hedda Wardemann
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  UPARSE: highly accurate OTU sequences from microbial amplicon reads.

Authors:  Robert C Edgar
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

Review 3.  Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.

Authors:  Louis J Cohen; Judy H Cho; Dirk Gevers; Hiutung Chu
Journal:  Gastroenterology       Date:  2019-03-14       Impact factor: 22.682

4.  Proposing a resolution to debates on diversity partitioning.

Authors:  Anne Chao; Chun-Huo Chiu; T C Hsieh
Journal:  Ecology       Date:  2012-09       Impact factor: 5.499

5.  The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.

Authors:  Rodrigo Bibiloni; Marco Mangold; Karen L Madsen; Richard N Fedorak; Gerald W Tannock
Journal:  J Med Microbiol       Date:  2006-08       Impact factor: 2.472

6.  Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.

Authors:  Jessica D Forbes; Gary Van Domselaar; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

Review 7.  Environmental risk factors for inflammatory bowel diseases: a review.

Authors:  Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

8.  An automated method for finding molecular complexes in large protein interaction networks.

Authors:  Gary D Bader; Christopher W V Hogue
Journal:  BMC Bioinformatics       Date:  2003-01-13       Impact factor: 3.169

9.  Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.

Authors:  J Alfredo Blakeley-Ruiz; Alison R Erickson; Brandi L Cantarel; Weili Xiong; Rachel Adams; Janet K Jansson; Claire M Fraser; Robert L Hettich
Journal:  Microbiome       Date:  2019-02-11       Impact factor: 14.650

10.  Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases.

Authors:  Heather Armstrong; Misagh Alipour; Rosica Valcheva; Michael Bording-Jorgensen; Juan Jovel; Deenaz Zaidi; Prachi Shah; Yuefei Lou; Cory Ebeling; Andrew L Mason; Dawson Lafleur; Jeremy Jerasi; Gane K-S Wong; Karen Madsen; Matthew W Carroll; Hien Q Huynh; Levinus A Dieleman; Eytan Wine
Journal:  Microbiome       Date:  2019-01-03       Impact factor: 14.650

View more
  5 in total

1.  Different Fecal Microbiota in Hirschsprung's Patients With and Without Associated Enterocolitis.

Authors:  Alexis P Arnaud; Ianis Cousin; Françoise Schmitt; Thierry Petit; Benoit Parmentier; Guillaume Levard; Guillaume Podevin; Audrey Guinot; Stéphan DeNapoli; Erik Hervieux; Valérie Flaum; Philine De Vries; Gwénaëlle Randuineau; Sandrine David-Le Gall; Sylvie Buffet-Bataillon; Gaëlle Boudry
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

2.  Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism.

Authors:  Hao Cheng; Juan Liu; Dandan Zhang; Jing Wang; Yuzhu Tan; Wuwen Feng; Cheng Peng
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

3.  The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder.

Authors:  Tom Knuesel; M Hasan Mohajeri
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

4.  Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile.

Authors:  Hao-Ming Xu; Hong-Li Huang; Yan-Di Liu; Jia-Qi Zhu; You-Lian Zhou; Hui-Ting Chen; Jing Xu; Hai-Lan Zhao; Xue Guo; Wei Shi; Yu-Qiang Nie; Yong-Jian Zhou
Journal:  BMC Microbiol       Date:  2021-10-16       Impact factor: 3.605

5.  Sodium Humate Alleviates Enterotoxigenic Escherichia coli-Induced Intestinal Dysfunction via Alteration of Intestinal Microbiota and Metabolites in Mice.

Authors:  Dong Wang; Yanjun He; Kexin Liu; Shouxiang Deng; Yuying Fan; Yun Liu
Journal:  Front Microbiol       Date:  2022-03-25       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.